Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura

Pediatric Blood and Cancer

Volumn 47, Issue 5 SUPPL., 2006, Pages 657-659

  Hazzan, Rawi ^a,b   Mukamel, Mashaand ^a,b   Yacobovich, Joanne ^a,b   Yaniv, Isaac ^a,b   Tamary, Hannah ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti nuclear antibody; Children; ITP; SLE

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; AUTOIMMUNE DISEASE; CHILD; FEMALE; FUTUROLOGY; HIGH RISK PATIENT; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE SYSTEM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION;

ANTIBODIES, ANTINUCLEAR; CHILD; CHRONIC DISEASE; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISRAEL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 33748477281     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20970     Document Type: Review

References (13)

1. Nathan DG, Ginsburg D, Orkin SH, editors. Hematology of infancy and childhood. Philadelphia: WB Saunders, 2003. pp 1601-1609.
2. Mestanza PM, Ariza AR, Cardiel MH, et al. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatology 1997;24:860-870.
3. Perez HD, Katler E, Embury S. Idiopathic thrombocytopenic purpura with high titer, speckled pattern antinuclear antibodies: possible marker for systemic lupus erthematosus. Arthritis Rheum 1985;28:596-597.
4. Anderson MJ, Peebles CL, Mcmillan R, et al. Fluorescent antinuclear antibodies anti SSa/Ro in patients with immune thrombocytopenia subsequently developing systemic lupus erythematosus. Ann Intern Med 1985;103:548-550.
5. Panzer S, Penner E, Graniger W, et al. Antinuclear antibodies in patients with chronic idiopathic autoimmune thrombocytopenia followed 2-30 years. Amer J Hematol 1989;32:100-103.
6. Kurata Y, Miyagawa S, Kosugi S. High titer antinuclear antibodies; anti SSa and antinuclear RNP antibodies in patients with Idiopathic thrombocytopenic purpura. Thronb Haemost 1994;71:184-187.
7. Zimmerman SA, Ware RE. Clinical significance of antinuclear antibodies test in selected children with idiopathic thrombocytopenic purpura. J Pediat Hematol Oncol 1997;19:297-305.
8. BMDP Statistical Software 1993. Dixon WJ. Chief editor: Berkely, CA, USA: University of California Press.
9. Tan EM, Cohen AS, Fries JS, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
10. Adachi M, Mita S, Obana M, et al. Thrombocytopenia subsequently develops systemic lupuserthymatosus-can anti SSa antibody predict the next event? Jpn J Med 1990;29:481-486.
11. Iyori H, Bessho F, Ookawa H, et al. Intracranial hemorrhage in children with immune thrombocytopenia purpura. Ann Hematol 2000;79:691-695.
12. Karen EH, Jon A, Alan JB. Autoantibodies and common viral illnesses. Semin Arthritis Rheum 1998;27:263-277.
13. Carbal DA, Petty RE, Fung M. Persistent antinuclear antibodies in children without identifiable inflammatory, rheumatic or autoimmune disease. Pediatrics 1992;98:441-444.